Felicia Ceban
Research collaborator in psychiatry and psychopharmacology
Papers
5 publications
Trials
0 clinical trials
Key Impact
She is a recurring author on ketamine and psychedelic-related psychiatric reviews, contributing to evidence syntheses on treatment-resistant depression, adverse effects, and hallucinogen persisting perceptual disorder.
Background & Research
Felicia Ceban is a Canadian mental health researcher and coauthor on multiple systematic reviews and meta-analyses in mood disorders and ketamine psychiatry. Her publications place her within the University Health Network / University of Toronto research ecosystem, with work spanning ketamine efficacy, safety, pharmacogenomics, and related psychiatric topics.
Collaboration Network
14 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Depressive DisordersTreatment-Resistant Depression (TRD)Safety & Risk ManagementMajor Depressive Disorder (MDD)Chronic PainSuicidalityAnxiety DisordersNeuroimaging & Brain MeasuresBipolar DisorderImmunology & InflammationPublic Health, Prevention & Behaviour ChangeAdolescentsOlder AdultsHealthy VolunteersMedicinal Chemistry & Drug DevelopmentHealth Economics & Reimbursement